Arcosa (ACA)
(Delayed Data from NYSE)
$89.73 USD
+1.67 (1.90%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $89.82 +0.09 (0.10%) 7:58 PM ET
1-Strong Buy of 5 1
B Value D Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ACA 89.73 +1.67(1.90%)
Will ACA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ACA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACA
Granite (GVA) Boosts Backlog With $27M Project by Caltrans
Here's Why You Must Retain Louisiana-Pacific (LPX) Stock Now
ACA: What are Zacks experts saying now?
Zacks Private Portfolio Services
OTIS Set to Enhance Sydney Metro - Western Sydney Airport
Granite (GVA) & Kraemer JV Wins $113M Project in Michigan
Tutor Perini (TPC) Boosts Backlog With New $48.6M Project
Other News for ACA
GLOBAL BROKER RATINGS: UBS likes Ameren; MWB and Kepler cut Sartorius
Arcosa, Inc. Announces Timing of Second Quarter 2024 Earnings Release and Conference Call
GLOBAL BROKER RATINGS: Oddo cuts Lufthansa, UBS raises Credit Agricole
RBC Capital Keeps Their Hold Rating on Credit Agricole (0HAI)
PRESS: London overtakes Paris as Europe’s biggest stock market